Supporting self-medication with cutting-edge assembly solutions

Pens and auto-injectors are highly sought-after administration solutions for injectables. From insulin to autoimmune applications and novel GLP-1s, the trend towards self-medication is continuing to rise. In parallel, the demand for new medical device manufacturing solutions is also increasing. And this is exactly where Syntegon comes into play: We offer pharmaceutical manufacturers and CDMOs highly flexible and modular assembly systems that answer all current challenges.

The market for self-medication is developing faster than ever before. Numerous new pharmaceuticals are being introduced, while further products are currently in the development phase. New GLP-1s, for example, enable patients to achieve significant weight reduction and offer an important means of combating obesity and preventing type 2 diabetes. Most of these novel drugs are administered as injectables. Hence, both pharmaceutical manufacturers and CDMOs need to expand their device manufacturing and assembly capabilities to keep up with this high demand.

Learn more

Challenges and solutions in autoinjector assembly

The challenges in this rapidly expanding market are manifold. Currently, pens and autoinjectors are in greater demand than supply, especially for GLP-1s. Pharmaceutical manufacturers and CDMOs require high capacities and the equipment to handle them accordingly. In parallel, many pharmaceutical companies are developing high-cost drugs without knowing their market success. Once developed and approved, fast time to market is crucial – and so is the matching assembly equipment.

Syntegon makes sure you can solve all these challenges. With our many years of experience, a comprehensive assembly portfolio with a standardized and scalable platform, as well as an agile project organization, we are your ideal partner for your pen and autoinjector assembly requirements. Our experts will help you navigate market demands more efficiently, while our technology makes sure your assembly processes are as smooth as can be.

Scalable technological excellence

From clinical trials to commercial production, and from stand-alone to fully integrated lines, we have the ideal solution for the assembly of your injection devices. Our manual, semi-automated, and fully automated equipment ensures the highest flexibility, modularity, and availability. Our rotary and linear pen and autoinjector assembly platforms achieve outputs of between 3 and 200 parts per minute. They can be flexibly scaled and automated according to your specific requirements.

Your benefits at a glance

Modular design facilitates the implementation of new products and output requirements
High availability thanks to competitive delivery times, spare parts accessibility, and fast service support
Seamless scalability from clinical trials to commercial production with our standardized platform
Highly efficient assembly with maximum OEE and fast changeovers between device types and batches

What can we do to enhance your pen and autoinjector assembly processes?

Contact our experts today